Literature DB >> 27754879

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Barbara S Wiggins, Joseph J Saseen, Robert L Page, Brent N Reed, Kevin Sneed, John B Kostis, David Lanfear, Salim Virani, Pamela B Morris.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; anti-arrhythmic agents; anticoagulants; calcium channel blockers; cardiovascular disease; drug-related side effects and adverse reactions; fenofibrate/fenofibric acid derivatives; gemfibrozil; hydroxymethylglutaryl-CoA reductase inhibitors; immunosuppressive agents

Mesh：

Substances：

Year:  2016        PMID： 27754879     DOI： 10.1161/CIR.0000000000000456

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  56 in total

1.  Prevention and management of statin adverse effects: A practical approach for pharmacists.

Authors:  Arden R Barry; Jessica E Beach; Glen J Pearson
Journal:  Can Pharm J (Ott)       Date:  2018-04-04

2.  One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins.

Authors:  Michael A Campitelli; Colleen J Maxwell; Laura C Maclagan; Dennis T Ko; Chaim M Bell; Lianne Jeffs; Andrew M Morris; Kate L Lapane; Nick Daneman; Susan E Bronskill
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

Review 3.  Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.

Authors:  Leigh Anne Hylton Gravatt; Rachel W Flurie; Estela Lajthia; Dave L Dixon
Journal:  Curr Atheroscler Rep       Date:  2017-10-09       Impact factor: 5.113

4.  Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining.

Authors:  Camille Morival; Richard Westerlynck; Guillaume Bouzillé; Marc Cuggia; Pascal Le Corre
Journal:  Eur J Clin Pharmacol       Date:  2017-12-18       Impact factor: 2.953

Review 5.  Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice.

Authors:  Alberto Corsini; Nicola Ferri; Marco Proietti; Giuseppe Boriani
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546

Review 6.  Use of Statins in Patients With and Without Liver Disease.

Authors:  Prashanth Francis; Lisa Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-02-25

7.  Role of Sodium Taurocholate Cotransporting Polypeptide as a New Reporter and Drug-Screening Platform: Implications for Preventing Hepatitis B Virus Infections.

Authors:  Menq-Rong Wu; Yi-You Huang; Jong-Kai Hsiao
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 8.  Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.

Authors:  Michael M Hoffmann
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

9.  Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population.

Authors:  Gillian E Caughey; Genevieve M Gabb; Saffron Ronson; Michael Ward; Timothy Beukelman; Catherine L Hill; Vidya Limaye
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

Review 10.  Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine.

Authors:  Aldo L Schenone; Venu Menon
Journal:  Curr Cardiol Rep       Date:  2018-06-14       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.